GERM-02. NOVEL TREATMENT APPROACH FOR PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) PURE EMBRYONAL CARCINOMA WITH INTENSIVE INDUCTION AND CONSOLIDATION MARROW-ABLATIVE CHEMOTHERAPY FOLLOWED BY AN ANTI-CD30 ANTIBODY-DRUG CONJUGATE, WITHOUT IRRADIATION

BACKGROUND: Primary CNS embryonal carcinoma confers a poor prognosis despite conventional chemotherapy and radiotherapy. We report upon a novel treatment approach to CNS embryonal carcinoma using intensive, including marrow-ablative, chemotherapy followed by maintenance therapy with brentuximab-vedo...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Abu Arja, Mohammad H, Conley, Suzanne E, AbdelBaki, Mohamed S, Osorio, Diana S, Coven, Scott, Abu-Arja, Rolla T, Boué, Daniel, Ginn, Kevin, Leonard, Jeffrey, Finlay, Jonathan L
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012627/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.251
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires